Clariant Completes Acquisition of Lucas Meyer Cosmetics

Clariant, a specialty chemical company, announced it has completed the acquisition of Lucas Meyer Cosmetics, a provider of high-value ingredients for the cosmetics and personal care industry, from IFF for an Enterprise Value (EV) of $810 million (€746 million). The purchase price will be subject to customary net debt and working capital adjustments.

“The acquisition of Lucas Meyer Cosmetics is a prime example of how we implement our purpose-led growth strategy and support our goal of accelerating customer- and sustainability-driven innovation,” commented Conrad Keijzer, Chief Executive Officer of Clariant. “The complementarity in customer portfolio, product portfolio, and regional strongholds and capabilities in R&D and in marketing make the combination of Clariant and Lucas Meyer Cosmetics a leading solutions provider for high-value personal care brands.”

Clariant is set to consolidate its portfolio towards specialty chemicals businesses and consumer end-markets, with a focus on natural and sustainable products. The company is increasing its exposure to the active and functional cosmetic ingredients market through the acquisition of Lucas Meyer Cosmetics, which will be consolidated into its Business Unit Care Chemicals from April 2, 2024. The CHF 350 million (€355 million) acquisition was funded through a dual-tranche senior unsecured bond and a multi-currency bridge facility, with plans for refinancing in 2024. Clariant anticipates its investment-grade credit rating to remain unchanged post-acquisition.

“I see the acquisition of Lucas Meyer Cosmetics as a significant step forward for Care Chemicals. Customers as well as consumers increasingly demand high-value natural ingredients,” said Christian Vang, President of the Clariant Business Unit Care Chemicals and the Americas region. “I extend a warm welcome to 190 highly qualified professionals as our new colleagues at Clariant. We jointly look forward to exciting growth opportunities and expect to increase annual sales to $180 million (€165 million) in 2028 from around $100 million (€92 million) currently.”

Clariant-Headquarter in Pratteln © Clariant
Clariant-Headquarter in Pratteln © Clariant

Company

Logo:

Clariant International Ltd

Rothausstr. 61
CH-4132 Muttenz
Switzerland

Company contact







Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

Virtual Event

DIGITALIZATION IN THE CHEMICAL INDUSTRY

DIGITALIZATION IN THE CHEMICAL INDUSTRY

Save the Date: October 22, 2025
The event will be promoted to a combined audience of over 100,000 professionals across Europe through the CHEManager and CITplus networks.